Sadhana Nitrochem Limited (SADHNANIQ)

Loading page…

Sadhana Nitrochem Limited (SADHNANIQ) · mywealthgrid

About

Sadhana Nitrochem operates in commodity chemicals, capital-intensive Materials segment with market cap of ₹930.92 Crores. Recent operations show recovery (Jun 2026: ₹26–27 Cr revenue, 8–9% OPM) but net losses persist; share price down 51.54% year-over-year reflects investor skepticism.

Face value: ₹1

Market cap

₹732 Cr

P/E

—

P/B

1.6×

Dividend yield

6.1%

ROE

-23.5%

ROCE

-12.8%

Debt / equity

0.24

OPM

-106.8%

EPS (TTM)

₹-0.3

Book value

₹1.5

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Persistent net losses (₹0.4–33.83 Cr per quarter) despite recent operational improvements; negative ROE (-23.52%) and overall OPM (-106.8%)
Revenue and margin volatility: Jun 2026 shows ₹26–27 Cr and 8–9% OPM, but Sep 2025 was ₹0.26–2.7 Cr and -628% OPM, indicating operational instability
Stock devaluation with 52-week range ₹1.33–₹11.08 and minimal institutional participation (FII 0.04%, DII 0.04%)
Rights issue in Feb 2026 signals capital strain; verify impact of dilution and whether raised capital enables sustainable operations

Generated analysis · source review pending

Growth drivers

Jun 2026 operational recovery (₹26–27 Cr revenue, 8–9% OPM) vs Sep 2025 nadir (₹0.26–2.7 Cr, -628% OPM); verify if production scale reaches net profitability
Rights issue capital (Feb 2026) may have enabled production ramp evident in Jun 2026; verify deployment to operations or capex
Moderate leverage (D/E 0.24) allows additional financing for turnaround without over-stretch

Generated analysis · source review pending

1,603 historical price candles were omitted because the exchange source has not been verified.

₹2.5-4.6%1Y

Quick read

rule-based

Pros

+Dividend yield of 6.1%
+High promoter holding of 60.9% with no pledge

Cons

−Low return on equity of -6.2% (3-yr avg)
−Revenue shrank over the last 3 years (-29.8% a year)
−Weak interest coverage of -2.3×

Research score

Structured signal from quality, growth, valuation and momentum.

39/100

Business quality: 18
Growth: 3
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Deepak Fertilizers And Petrochemicals Corporation LimitedDEEPAKFERTDEEPAKFERT	₹16,417 Cr	₹21,903 Cr	₹12,104 Cr	₹2,016 Cr	14.6%	₹984 Cr	6.4%	12.6%	11.3%	55
Tata Chemicals LimitedTATACHEMTATACHEM	₹15,487 Cr	₹23,488 Cr	₹15,120 Cr	₹1,711 Cr	12.4%	₹-2,165 Cr	-11.8%	2.9%	-8.9%	113
Gujarat Narmada Valley Fertilizers And Chemicals LimitedGNFCGNFC	₹8,655 Cr	₹8,655 Cr	₹8,410 Cr	₹1,241 Cr	11.3%	₹1,037 Cr	10.4%	10.6%	9.1%	81
TANFAC Industries LtdTANFACINDTANFACIND	₹6,909 Cr	₹7,002 Cr	₹711 Cr	₹112 Cr	15.8%	₹70 Cr	9.9%	27.7%	20.5%	112
Gujarat Alkalies And Chemicals LimitedGUJALKALIGUJALKALI	₹4,430 Cr	₹4,998 Cr	₹4,498 Cr	₹510 Cr	9.3%	₹66 Cr	-0.1%	1.6%	-0%	25
Grauer & Weil India LimitedGRAUWEILGRAUWEIL	₹3,709 Cr	₹3,717 Cr	₹1,134 Cr	₹188 Cr	16.6%	₹69 Cr	13.9%	23%	18%	72
Ghcl LimitedGHCLGHCL	₹3,700 Cr	₹3,762 Cr	₹3,064 Cr	₹689 Cr	22.5%	₹472 Cr	15.4%	17%	13.4%	126
J.g.chemicals LimitedJGCHEMJGCHEM	₹2,392 Cr	₹2,399 Cr	₹1,071 Cr	₹96 Cr	8.4%	₹75 Cr	7.1%	18.2%	13.3%	101
Thirumalai Chemicals LimitedTIRUMALCHMTIRUMALCHM	₹1,764 Cr	₹3,857 Cr	₹1,832 Cr	₹20 Cr	-2%	₹-152 Cr	-9.7%	-3.3%	-12.3%	14
Ig Petrochemicals LimitedIGPLIGPL	₹1,754 Cr	₹2,110 Cr	₹2,073 Cr	₹207 Cr	4.9%	₹82 Cr	0.1%	3.2%	0.2%	23
Indo Borax & Chemicals LimitedINDOBORAXINDOBORAX	₹1,507 Cr	₹1,507 Cr	₹232 Cr	₹52 Cr	20.5%	₹56 Cr	23.3%	15.5%	15.1%	110
Innovassynth Technologies (India) LtdINOVSYNTHINOVSYNTH	₹1,462 Cr	₹1,466 Cr	₹0 Cr	₹-0 Cr	—	₹-5 Cr	—	-1.1%	-12%	—

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	132	143	190	166	50
COGS	74	70	85	63	56
Gross profit	58	73	105	103	-6
	43	52	64	61	47
	15	21	41	42	-53
OPM %	11.1%	14.8%	21.6%	25.6%	-106.8%
Depreciation	6	8	15	15	16
Interest	5	10	17	18	26
	5	2	4	2	9
Profit before tax	9	6	13	12	-87
Tax	3	2	9	4	-1
Tax %	30.2%	44.1%	68.2%	34.3%	-1%
	6	3	4	8	-86
PAT margin %	4.7%	2.2%	2.2%	4.6%	-174%
EPS (₹)	—	0.2	0.2	0.2	-2
EPS adjusted (₹)	0.3	0.1	0.2	0.2	-0.3
	—	93.8%	88.2%	0%	—
Annual report	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	14	20	20	25	33	296
Reserves	—	141	206	202	248	158
	—	106	132	221	235	109
	—	120	108	84	121	95
Total equity & liabilities	—	386	466	532	637	658
	72	75	144	156	156	161
CWIP	—	65	25	53	100	78
Investments	—	7	6	6	3	0
	—	239	292	317	378	419
Total assets	—	386	466	532	637	658

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-5	-38	-2	48	-29
	-39	-53	-65	-89	-46
	46	72	41	25	93
Net cash flow	2	-19	-26	-16	18
Free cash flow	-43	-80	-68	-46	-93
CFO / Operating profit %	-32.2%	-178.1%	-5.8%	113%	—

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	43.9%	51.1%	55.5%	62.2%	-12.4%
EBITDA margin %	11.1%	14.8%	21.6%	25.6%	-106.8%
EBIT margin %	6.5%	9.5%	13.8%	16.4%	-139.7%
PAT margin %	4.7%	2.2%	2.2%	4.6%	-174%
Working capital
Receivable days	113	167	242	270	977
Inventory days	497	604	495	789	641
Payable days	219	174	143	282	314
NWC days	392	596	594	776	1,304
Leverage
Current ratio	1.23	1.57	1.68	1.39	1.8
Debt to EBITDA	7.22	6.21	5.37	5.55	—
Debt to equity	0.66	0.58	0.97	0.84	0.24
Interest coverage	2.9	1.6	1.7	1.7	-2.3
Asset turnover	0.34	0.31	0.36	0.26	0.08
Return ratios
Return on assets %	1.6%	0.7%	0.8%	1.2%	-13.1%
Return on capital employed %	6.5%	6.1%	9%	7.1%	-12.8%
Return on equity %	3.9%	1.4%	1.8%	2.7%	-19%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	71.12%	65.81%	65.65%	65.48%	65.47%	65.11%	64.9%	56.73%	29.97%	29.97%	60.9%	60.9%
	0%	0%	0.05%	0%	0%	0%	0.05%	0.04%	0.04%	0.14%	0%	0.04%
	0.02%	0.05%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.07%	0.07%	0.01%	0.04%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	28.86%	34.14%	34.28%	34.5%	34.51%	34.87%	35.03%	43.21%	69.92%	69.82%	39.09%	39.02%
No. of shareholders	—	—	—	—	—	—	—	—	63,144	64,258	68,448	75,881

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Sadhana Nitrochem Limited. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

16 announcementsExport CSV

10 Aug 2026, 11:45 amCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

7 Aug 2026, 7:56 pmCompany Update

Compliances-Statement Of Deviation Or Variation Of Funds Utilised Through The Rights Issue For The Quarter Ended June 30, 2026

Reg. 32 (1), (3) - Statement of Deviation & Variation PDF

7 Aug 2026, 7:53 pmCompany Update

Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Monitoring Agency Report PDF

7 Aug 2026, 7:45 pmResult

Results-Financial Results For June 30, 2026

Financial Results PDF

7 Aug 2026, 7:30 pmBoard Meeting

Board Meeting Outcome for Outcome Of Board Meeting

Outcome of Board Meeting PDF

31 Jul 2026, 4:06 pmBoard Meeting

Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Along With The Limited Review Report Of The Company For The Quarter Ended June 30, 2026.

Exchange filing PDF

28 Jul 2026, 4:44 pmCompany Update

Receipt Of In-Principle Approval From BSE Limited ('BSE') And National Stock Exchange Of India Limited ('NSE') For Proposed Preferential Issue Of 6,75,00,000 Equity Shares Of Re. 1/- Each Of The Company.

General PDF

9 Jul 2026, 2:48 pmCompany Update

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 PDF

Date	Category	Subject	Filing
10 Aug 2026, 11:45 am	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
7 Aug 2026, 7:56 pm	Company Update Reg. 32 (1), (3) - Statement of Deviation & Variation	Compliances-Statement Of Deviation Or Variation Of Funds Utilised Through The Rights Issue For The Quarter Ended June 30, 2026

Loading announcements…

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	43.9%	51.1%	55.5%	62.2%	-12.4%
EBITDA margin %	11.1%	14.8%	21.6%	25.6%	-106.8%
EBIT margin %	6.5%	9.5%	13.8%	16.4%	-139.7%
PAT margin %	4.7%	2.2%	2.2%	4.6%	-174%
Working capital
Receivable days	113	167	242	270	977
Inventory days	497	604	495	789	641
Payable days	219	174	143	282	314
NWC days	392	596	594	776	1,304
Leverage
Current ratio	1.23	1.57	1.68	1.39	1.8
Debt to EBITDA	7.22	6.21	5.37	5.55	—
Debt to equity	0.66	0.58	0.97	0.84	0.24
Interest coverage	2.9	1.6	1.7	1.7	-2.3
Asset turnover	0.34	0.31	0.36	0.26	0.08
Return ratios
Return on assets %	1.6%	0.7%	0.8%	1.2%	-13.1%
Return on capital employed %	6.5%	6.1%	9%	7.1%	-12.8%
Return on equity %	3.9%	1.4%	1.8%	2.7%	-19%

59 deals · 29 Sept 2023 – 27 Mar 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
27 Mar 2026	NIRAJ BAJAJ	Bulk	BSE	Buy	14,75,00,000	₹1.30	₹19.18 Cr
27 Mar 2026	ABHISHEK ASIT JAVERI	Bulk	BSE	Sell	7,38,00,000	₹1.30	₹9.59 Cr
27 Mar 2026	ASIT DHANKUMAR JAVERI	Bulk	BSE	Sell	7,26,98,864	₹1.30	₹9.45 Cr
25 Mar 2026	ANKITA VISHAL SHAH	Bulk	NSE	Buy	2,04,31,864	₹1.33	₹2.72 Cr
25 Mar 2026	ANKITA VISHAL SHAH	Bulk	NSE	Sell	1,19,85,111	₹1.38	₹1.65 Cr
24 Feb 2026	MANSI SHARE AND STOCK BROKING PRIVATE LIMITED	Bulk	NSE	Sell	21,78,943	₹2.30	₹0.50 Cr
1 Sept 2025	NEO APEX VENTURE LLP	Bulk	NSE	Sell	19,00,000	₹8.82	₹1.68 Cr
1 Sept 2025	MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	NSE	Sell	18,97,011	₹8.82	₹1.67 Cr
25 Aug 2025	NEO APEX VENTURE LLP	Bulk	NSE	Sell	24,00,000	₹7.26	₹1.74 Cr
25 Aug 2025	MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	BSE	Sell	17,57,699	₹7.39	₹1.30 Cr

1–10 of 59

1 / 6

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Sadhana Nitrochem Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Announcements

Ratio timeline

Not in the F&O segment

No fund holdings on record

Announcements

Quarterly record

Annual reports

Dividends7

Board meetings1

Stock splits2

Bulk & block deals

Board and management

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Return on equity

7

1

2